Scan trial to track a new tracer in suspected bacterial infections
Part of Infections clinical trials.
This Phase 1 study uses a special scan tracer ([18F]F-TMP) to see how it moves in the body and how fast it changes in people with suspected or known bacterial infections. It’s mainly testing the scan’s behavior and safety, which may help future infection-targeting imaging.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old
- Have a known or suspected bacterial infection confirmed by your medical team
- Be able to understand the study and sign consent before any study procedures
- Have not taken trimethoprim antibiotics within 48 hours before your baseline scan
- Be able to tolerate PET/CT imaging safely (lie still and complete the scan)
- Not be pregnant or breastfeeding (pregnancy testing will be done if able to become pregnant)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET/CT scan with a new tracer to see how TB infection looks in the lungs. It may help doctors better understand and treat TB.
This Phase 1 study tests a new PET/CT imaging tracer to see how well it can detect breast cancer spots in the body. It may help doctors learn where breast cancer is and how imaging could work better in the future.
This study follows people with prostate cancer whose PSA blood test has risen again after standard treatment. It uses an approved PET scan tracer to look for cancer spread, which may help doctors understand how the disease is progressing.
This study tests how well an FTT PET/CT scan can detect and measure metastatic (spread) prostate cancer. It may help your care team decide on the best next treatment plan, especially if you need to change or start therapy.
This Phase 1 study tests whether a new PET imaging tracer (a small amount of radioactive medicine) is safe and how it moves through the body. It’s mainly for adults with cancer who have signs of inflammation or possible immune side effects, so doctors can see what’s happening in the body.
This early-phase study uses PET/CT scans to see how well a new radioactive tracer (a tiny dose of a special material) highlights solid tumors in the body. It may help researchers learn whether this tracer can better find and track tumor spots seen on standard scans.
Hear when a new Bacterial Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.